Modified vaccinia virus ankara (MVA) as production platform for vaccines against influenza and other...
Modified vaccinia virus ankara (MVA) as production platform for vaccines against influenza and other viral respiratory diseases
About this item
Full title
Author / Creator
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
Respiratory viruses infections caused by influenza viruses, human parainfluenza virus (hPIV), respiratory syncytial virus (RSV) and coronaviruses are an eminent threat for public health. Currently, there are no licensed vaccines available for hPIV, RSV and coronaviruses, and the available seasonal influenza vaccines have considerable limitations. W...
Alternative Titles
Full title
Modified vaccinia virus ankara (MVA) as production platform for vaccines against influenza and other viral respiratory diseases
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_ce4dd81d53d1421d889e1886836f84f1
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ce4dd81d53d1421d889e1886836f84f1
Other Identifiers
ISSN
1999-4915
E-ISSN
1999-4915
DOI
10.3390/v6072735
